{"brief_title": "Safety and Effectiveness of Giving Two Nucleoside Reverse Transcriptase Inhibitors Alone or in Combination With 141W94 to HIV-Infected Children Who Have Never Received Protease Inhibitors", "brief_summary": "The purpose of this study is to see if it is safe and effective to add a new protease inhibitor (PI), 141W94, to an anti-HIV regimen that includes 2 nucleoside reverse transcriptase inhibitors (NRTIs).", "detailed_description": "In this double-blind, placebo-controlled, pediatric study, 210 patients are randomized to receive 2 NRTIs plus either 141W94 or placebo. Enrollment of patients is sequential: patients 13 to 18 years of age are enrolled first, followed by children < 13 when the appropriate pediatric dose has been determined. Patients who are unable to swallow capsules will be accrued when a liquid formulation becomes available.", "condition": "HIV Infections", "intervention_type": "Drug", "intervention_name": "Amprenavir", "criteria": "Inclusion Criteria Your child may be eligible for this study if he/she: - Is 6 months - 18 years of age. - Is HIV-positive. - Has a viral load (level of HIV in the body) greater than 10,000 copies/ml. - Is able to take medications by mouth. - Has consent of parent or legal guardian if under 18. - Has a negative pregnancy test within 7 days of study entry. - Agrees to practice abstinence or use effective methods of birth control for 1 month before and throughout the study. Exclusion Criteria Your child will not be eligible for this study if he/she: - Has a serious illness, including any life-threatening infection or other chronic serious medical condition. - Has an opportunistic (AIDS-related) infection or a serious bacterial infection. - Is allergic to NRTIs. - Is breast-feeding. - Is unlikely to complete the study. - Has received certain medications. - Has received radiation therapy within the past 4 months, or will need to receive it during the study.", "gender": "All", "minimum_age": "6 Months", "maximum_age": "18 Years", "healthy_volunteers": "No", "id": "NCT00002193.xml"}